Richard T Maziarz Selected Research

tisagenlecleucel

1/2022	Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma.
1/2022	Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
1/2022	Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.
1/2022	Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison.
1/2022	Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States.
10/2021	Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
11/2020	Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
1/2020	Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial.
1/2020	Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.
1/2020	Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard T Maziarz Research Topics

Disease

22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2006
21	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 04/2004
19	Neoplasms (Cancer) 10/2021 - 09/2004
18	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 08/2003
18	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 11/2008
16	Leukemia 01/2022 - 02/2006
15	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 09/2004
13	Multiple Myeloma 01/2018 - 04/2009
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2008
10	Lymphoma (Lymphomas) 01/2022 - 04/2003
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2015 - 09/2003
7	Bronchiolitis Obliterans Syndrome 01/2022 - 05/2009
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2018
6	Infections 01/2022 - 03/2004
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2003
5	Disease Progression 10/2021 - 05/2012
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 03/2014
4	Injection Site Reaction 12/2013 - 06/2009
4	Invasive Fungal Infections 09/2013 - 05/2003
3	Bone Marrow Failure Disorders 12/2021 - 01/2009
3	Nausea 01/2021 - 05/2003
3	Diarrhea 01/2021 - 05/2003
3	Cytokine Release Syndrome 11/2020 - 01/2019
3	Blast Crisis (Blast Phase) 10/2020 - 04/2004
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2015 - 12/2004
3	Hodgkin Disease (Hodgkin's Disease) 03/2014 - 11/2008
3	Primary Myelofibrosis (Myelosclerosis) 01/2014 - 03/2010
2	Virus Diseases (Viral Diseases) 01/2022 - 04/2011
2	Communicable Diseases (Infectious Diseases) 02/2021 - 01/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 05/2007
2	Vomiting 01/2021 - 05/2003
2	Opportunistic Infections (Opportunistic Infection) 01/2020 - 01/2010
2	Residual Neoplasm 01/2019 - 03/2006
2	Pain (Aches) 01/2019 - 06/2004
2	Hematologic Diseases (Blood Diseases) 11/2017 - 07/2013
2	Thrombocytopenia (Thrombopenia) 09/2017 - 10/2012
2	Neutropenia 09/2017 - 12/2013
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 11/2003
2	Mycoses (Diseases, Fungus) 09/2013 - 05/2003
2	Pathologic Complete Response 07/2013 - 02/2012
2	Splenomegaly 03/2013 - 09/2012
2	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2013 - 11/2008
2	Tumor Lysis Syndrome 09/2010 - 09/2004
2	Philadelphia Chromosome 09/2006 - 04/2004
1	Herpesviridae Infections (Herpesvirus Infection) 01/2022
1	Viremia 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Hyperferritinemia 12/2021
1	Cytopenia 12/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2021
1	COVID-19 01/2020

Drug/Important Bio-Agent (IBA)

12	tisagenlecleucelIBA 01/2022 - 01/2019
12	fludarabineIBA 01/2021 - 12/2004
11	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 04/2006
8	plerixafor FDA Link 01/2018 - 06/2009
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2013
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2021 - 04/2006
5	Busulfan (Busulfex)FDA Link 01/2019 - 12/2013
5	HLA Antigens (Human Leukocyte Antigens)IBA 09/2014 - 12/2008
5	Imatinib Mesylate (Gleevec)FDA Link 10/2008 - 04/2004
4	Calcineurin InhibitorsIBA 01/2022 - 01/2015
3	tocilizumab (atlizumab)FDA Link 11/2020 - 01/2020
3	Rituximab (Mabthera)FDA Link 01/2020 - 10/2015
3	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 03/2014
3	Fluconazole (Zonal)FDA LinkGeneric 09/2013 - 05/2003
2	axicabtagene ciloleucelIBA 01/2022 - 01/2020
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 06/2004
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 02/2006
2	Bortezomib (Velcade)FDA Link 01/2018 - 10/2014
2	AntigensIBA 01/2018 - 08/2012
2	Lenalidomide (CC 5013)FDA Link 09/2017 - 05/2012
2	treosulfanIBA 04/2014 - 03/2011
2	SteroidsIBA 02/2014 - 09/2004
2	Voriconazole (Vfend)FDA LinkGeneric 09/2013 - 12/2010
2	Pharmaceutical PreparationsIBA 05/2012 - 05/2003
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2007 - 04/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Biological ProductsIBA 10/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	midostaurinIBA 01/2021
1	Clofarabine (Clolar)FDA Link 01/2021
1	trans-crotonin (CTN)IBA 01/2021
1	CD19 AntigensIBA 01/2021
1	VaccinesIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020

Therapy/Procedure

54	Cell Transplantation 01/2022 - 04/2004
41	Therapeutics 01/2022 - 04/2004
25	Transplantation 01/2022 - 04/2003
23	Hematopoietic Stem Cell Transplantation 01/2022 - 05/2003
16	Stem Cell Transplantation 10/2021 - 08/2003
13	Homologous Transplantation 01/2021 - 04/2009
12	Drug Therapy (Chemotherapy) 10/2021 - 06/2004
3	Autologous Transplantation 07/2013 - 02/2006
3	Hematopoietic Stem Cell Mobilization 04/2013 - 10/2009
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2004 - 04/2003
1	Haploidentical Transplantation 01/2022
1	Liver Transplantation 12/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020